Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast; Deformity, Congenital”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04744766
What this trial is testing

Central Mammary Duct Excision; How to Improve the Outcome?

Who this might be right for
Duct Ectasia BreastBenign Breast Disease
Alexandria University 130
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Ended earlyNCT04899349
What this trial is testing

Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 2
Not applicableUnknownNCT04127422
What this trial is testing

Risk Factors for Benign Breast Disease

Who this might be right for
Benign Breast Disease
Mansoura University 500
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Not applicableStudy completedNCT04407611
What this trial is testing

Scalable Communication Modalities for Returning Genetic Research Results

Who this might be right for
Hereditary Breast and Ovarian CancerLynch Syndrome
Boston University 926
Not applicableStudy completedNCT02753686
What this trial is testing

Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy

Who this might be right for
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
Novartis Pharmaceuticals 440
Large-scale testing (Phase 3)Ended earlyNCT03439046
What this trial is testing

Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 287
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 880
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Not applicableStudy completedNCT00001496
What this trial is testing

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

Who this might be right for
Breast NeoplasmHereditary Neoplastic Syndrome
National Cancer Institute (NCI) 50
Not applicableStudy completedNCT04883931
What this trial is testing

Mother Milk as a Eye Drop & Premature Retinopathy

Who this might be right for
Retinopathy of Prematurity
Baskent University 101
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableStudy completedNCT02452333
What this trial is testing

Oncoplastic Approach to Excisional Breast Biopsies

Who this might be right for
Neoplasm of Female BreastBreast Neoplasms DiagnosisBreast Diseases+1 more
Akdeniz University 80
Not applicableStudy completedNCT03030404
What this trial is testing

Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer

Who this might be right for
Stomach NeoplasmsStomach CancerGastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS)+2 more
National Cancer Institute (NCI) 733
Not applicableStudy completedNCT05364138
What this trial is testing

Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda

Who this might be right for
Breast CancerBenign Breast DiseaseCervix Cancer
Brigham and Women's Hospital 2,357
Testing effectiveness (Phase 2)Study completedNCT01100463
What this trial is testing

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

Who this might be right for
Palmar-Plantar ErythrodysesthesiaBreast Cancer
Nanometics (d.b.a. PHD Biosciences) 18
Large-scale testing (Phase 3)Ended earlyNCT03050398
What this trial is testing

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT02786147
What this trial is testing

Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer

Who this might be right for
Hereditary Breast and Ovarian Cancer
Emory University 665
Next Page